Friday, November 09, 2018

Investorideas.com - The AI Eye: Honeywell (NYSE: $HON) Acquires Transnorm, Fortinet (NasdaqGS: $FTNT) Announces 50 Security Fabric Solutions Have Been Approved for Dept. of Defense Product List

The AI Eye: Honeywell (NYSE: $HON) Acquires Transnorm, Fortinet (NasdaqGS: $FTNT) Announces 50 Security Fabric Solutions Have Been Approved for Dept. of Defense Product List

AI Chipset Market Could Grow to More Than $59 Billion by 2024 According to Market Research Engine Report

Point Roberts, WA and Vancouver, BC - November 9, 2018 (Investorideas.com Newswire) Investorideas.com (www.investorideas.com), a global investor news source covering Artificial Intelligence (AI) , in partnership with Gopher Protocol's (OTCQB: GOPH). Avant!, the latest innovation in machine learning, brings you today's edition of The AI Eye - Watching stock news, deal tracker and advancements in artificial intelligence.

Listen to today's podcast:

https://www.investorideas.com/Audio/Podcasts/2018/110918-AI-Eye.mp3

The AI Eye: Honeywell (NYSE: $HON) Acquires Transnorm, Fortinet (NasdaqGS: $FTNT) Announces 50 Security Fabric Solutions Have Been Approved for Dept. of #Defense Product List

Hear Investor Ideas Podcasts on iTunes

Today's Column - The AI Eye- Watching stock news, deal tracker and advancements in artificial intelligence

AI Chipset Market Could Grow to More Than $59 Billion by 2024 According to Market Research Engine Report

A report from Market Research Engine forecasts that the global AI chipset market could exceed $59 billion USD by 2024 with a compound annual growth rate of 36 percent. The report pegs the increasing demand of technology like specialized chipsets to the high growth in computing applications. It also lists the driving factors of the market as being: Increasingly large and complicated dataset driving the requirement for AI, adoption of AI for up client services and reducing operational prices, the growing range of AI applications and increasing computing power and declining hardware price. The report breaks the AI chipset market into four categories: Component type, Technology type, end-user type and regional analysis.

Honeywell Acquires Transnorm, Fortinet Announces 50 Security Fabric Solutions Have Been Approved for Dept. of Defense Product List and Datametrix AI Announces the Public Listing of Graph Blockchain, Inc.

Stocks discussed: (NYSE:HON) (NasdaqGS:FTNT) (TSX:DM.V) (CSE:GBLC)

Honeywell International Inc. (NYSE:HON) has completed the acquisition of Transnorm, a warehouse automation solutions provider. The German-based Transnorm was acquired from IK Investment Partners for €425 million EUR ($482 million USD). According to the press release, Transnorm will be integrated into Honeywell Safety and Productivity Solutions (SPS). John Waldron, president and CEO of Honeywell SPS, commented on the acquisition:

"Transnorm is an excellent addition to our portfolio of warehouse automation solutions, and will help us better support European distribution centers and parcel delivery providers that are responding to significant e-commerce growth. Our Connected Distribution Center offering delivers higher throughput, greater flexibility and better visibility into real-time operations to give our customers the ability to make better business decisions."

Fortinet, Inc. (NasdaqGS:FTNT), a global leader in high performance network security, today announced that over 50 additional Fortinet Security Fabric solutions have achieved Department of Defense Information Network (DoDIN) Approved Products List (APL) certification.

Datametrix AI Limited (TSX:DM.V) today announced that the Canadian Securities Exchange (CSE) has approved listing for the common shares of Graph Blockchain, Inc. According to the press release, Graph Blockchain, Inc. is the resulting issuer of the reverse takeover transaction between Graph Blockchain Limited, an associate company of Datametrex, and Reg Technologies Inc. The company will begin trading today on the CSE under the ticker symbol GBLC.

Sam Mowers, Investorideas.com

Read and hear other editions of the AI Eye

For a list of artificial intelligence stocks on Investorideas.com visit here or become an Investor Ideas member

Gopher Protocol's (OTCQB: GOPH) Avant! is the latest innovations in machine learning and is targeted to empower Gopher Protocol's wide range of IoT and mobile technologies. Avant! can be integrated into wide range of applications in a variety of fields among these are business, medicine, engineering, analytics and more. Avant! learns and enhances its expertise based on wide range of data sources and on its own. www.avant-ai.com.

AI expert Dr. Danny Rittman, CTO of Gopher Protocol Inc. (OTCQB: GOPH) is a semiconductor designer with over twenty years of experience with companies such as Intel (NasdaqGS: INTC), DEC, IBM (NYSE:IBM), and Qualcomm (NasdaqGS: QCOM). He has worked on many prestigious Integrated Circuits projects, among them the Intel's Pentium Pro, DEC's Alpha chip and others. Danny was the founder and CTO of BindKey Technologies, an EDA corporation that was acquired by DuPont Photo masks.

About Investorideas.com - News that Inspires Big Investing Ideas https://www.investorideas.com/

Investorideas.com is a recognized news source publishing third party news and press releases plus we create original financial content. Learn about investing in stocks and sector trends from Investorideas.com with our news alerts , articles , podcasts and videos talking about cannabis, crypto, technology including AI and IoT , mining ,sports biotech, water, renewable energy and more . Investorideas.com original branded content includes the daily Crypto Corner and Podcast, Play by Play sports and stock news column, Investor Ideas #Potcasts#Cannabis News and Stocks on the Move podcast and column, Cleantech and Climate Change Podcast and the AI Eye Podcast and column covering developments in AI.

The Investorideas.com podcasts are also available on iTunes, Spotify, Tunein, Stitcher, Spreaker.com, iHeartRadio and Google Play Music.

Visit the Podcast page at Investorideas.com:

https://www.investorideas.com/Audio/

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, contents creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Disclosure: Disclosure: GOPH is a PR, social media and publishing client and compensates Investorideas.com - More disclaimer info: shttps://www.investorideas.com/About/Disclaimer.asp , http://www.investorideas.com/About/News/Clientspecifics.

Learn more about our podcast and article services and costs https://www.investorideas.com/News-Upload/

Additional info regarding BC Residents and global Investors: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: https://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations of each country.

Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

The AI Eye - Watching stock news, deal tracker and advancements in artificial intelligence is an original content brand of Investorideas.com

Contact Investorideas.com

800 665 0411

Investorideas.com - #Cannabis after 2018 Midterms - Medical Marijuana laws now adopted in 31 states: DirectView Holdings (OTC: $DIRV), Cronos Group ( $CRON), Tilray ( $TLRY), Canopy Growth (TSX: $WEED.TO), (NYSE: $CGC)

Investorideas.com - #Cannabis after 2018 Midterms - Medical Marijuana laws now adopted in 31 states: DirectView Holdings (OTC: $DIRV), Cronos Group ( $CRON), Tilray ( $TLRY), Canopy Growth (TSX: $WEED.TO), (NYSE: $CGC)

#Cannabis after 2018 Midterms - Medical Marijuana laws now adopted in 31 states: DirectView Holdings (OTC: $DIRV), Cronos Group ( $CRON), Tilray ( $TLRY), Canopy Growth (TSX: $WEED.TO), (NYSE: $CGC)

Point Roberts, WA and Delta, BC - November 9, 2018 (Investorideas.com Newswire) Investorideas.com, a leading investor news resource covering security and cannabis stocks releases a snapshot looking at the growing global opportunity for the cannabis market as new States vote on legalization in the U.S. midterms.

Voters in Missouri approved Amendment 2 on Tuesday, making it the 31st state in the nation to adopt an effective medical marijuana law. The measure was leading 64-36 with 49 percent of precincts reporting when The New York Times called the election.

Effective medical marijuana laws have now been adopted in 31 states, including Missouri, as well as in D.C. and the U.S. territories of Guam, Puerto Rico and the Northern Mariana Islands. Eighteen other states have adopted medical marijuana laws that are ineffective because they are either unworkable or exceptionally restrictive. Idaho is the only state without any form of medical marijuana law.

Excited about the momentum, DirectView Holdings, Inc. (OTC:DIRV), a company focused on ownership and management of leading video and security technology companies, today announced that the Company's CEO, Roger Ralston and CFO, Chris Cutchens, will be attending the 2018 MJ Business Convention in Las Vegas, Nevada.

"The conference, held November 13th to 16th at The Las Vegas Convention Center, is the largest cannabis business conference in the world. MJBizCon is the preeminent conference to drive business deals and forge valuable connections with cannabis professionals in business today. The conference is estimated to house 20,000+ cannabis professionals and 1,000+ exhibitors for the preeminent event for industry professionals."

"DirectView management will attend the conference to meet with Cannabis industry professionals, showcase its state-of-the-art cannabis security and surveillance solutions and discuss the various regulations and mandatory security compliance requirements associated with the quickly evolving industry."

"DirectView recognizes a major opportunity for custom-tailored security, surveillance, access control and safety solutions that meet the regulatory and compliance requirements of the booming cannabis industry. According to the research report " Video Surveillance Market by System (Analog, & IP), Offering (Hardware, Software, & Service), Vertical (Commercial, Infrastructure, Military & Defense, Residential, Public Facility, & Industrial), and Geography - Global Forecast to 2023", the overall market is estimated to grow from USD 36.89 Billion in 2018 to USD 68.34 Billion by 2023, at a CAGR of 13.1% between 2018 and 2023. The increasing concerns for public safety and security, growing adoption of IP cameras, and growing demand for DIY and spy cameras are the key factors driving the video surveillance market growth."

Roger Ralston, President and CEO of DirectView said, "The cannabis industry is quickly taking off here, especially today after the midterm elections and the resignation of Attorney General Jeff Sessions. One of the major concerns in the Cannabis industry is Security. DirectView launched its initiative to provide and install custom-tailored security solutions for the cannabis industry. It goes without saying then, that DirectView's attendance at this conference is only natural. We are looking forward to meeting with and networking with industry professionals and educating them on DirectView security and surveillance solutions and the various compliance and regulations associated with the industry."

Paul Rosen, currently the CEO and Chairman of Tidal Royalty, a company that invests in U.S.-based cannabis companies, as well as an original co-founder of the Cronos Group (TSX: CRON), (NASDAQ:CRON) was quoted as saying, "I believe that Michigan legalizing adult use will one day be viewed as the tipping point towards full legalization at a national level. Aside from the fact that it is the 10th state to legalize adult use - and one of the most populous states in the nation - it is the first Midwest state to do so."

CBS News MoneyWatch took note of these big developments in the cannabis sector and the reaction from investors reporting, "Canadian pot company Tilray (NASDAQ:TLRY) rose 30 percent on news that U.S. Attorney Jeff Sessions would step down."

The article went on to say how not only were the companies "lifted by midterm ballot measure victories, but Tilray and other cannabis companies rose further on word Sessions had resigned. The nation's top law enforcer last January said he would work to revoke policy from the Obama administration that let states make their own rules on weed without hindrance from the federal government."

Continued: "Canopy Growth (TSX: WEED), (NYSE: CGC) and Aurora Cannabis, two other publicly traded Canadian pot companies, both rallied more than 8 percent.

Stocks in the sector were higher in after- hours trading as well on Wednesday.

As cannabis stocks continue to rise on the news of more and more favorable legislation, investors will be watching and waiting for the next big development; perhaps the passing of the 2018 U.S. Farm Bill under a new Democrat House.

Reuters reported, "Collin Peterson, ranking member and presumptive new chair of committee, said passing the crucial agricultural legislation was going to be his top priority, with a deal possible as soon as next week during the lame-duck session."

For investors following cannabis stocks, Investor Ideas has created a stock directory of publicly traded CSE, TSX, TSXV, OTC, NASDAQ, NYSE, ASX Marijuana/Hemp Stocks

About Investorideas.com - News that Inspires Big Investing Ideas

https://www.facebook.com/Investorideaspotcasts/

https://twitter.com/MJInvestorIdeas

https://www.instagram.com/potcasts_investorideas/

This news is published on the Investorideas.com Newswire - News that Inspires big ideas Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp. Disclosure: this news article featuring DIRV is a paid for news release on Investorideas.com - third party, Learn more about costs and our services https://www.investorideas.com/News-Upload/

Additional info regarding BC Residents and global Investors: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations of each country.

Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

Investor Ideas does not condone the use of cannabis except where permissible by law. Our site does not possess, distribute, or sell cannabis products.

Contact Investorideas.com

800-665-0411

Marijuana / Hemp Stocks

Like Marijuana / Hemp Stocks? View our Marijuana / Hemp Stocks Directory

Join our Group on Linkedin - Marijuana / Hemp Stocks - News and Trends in Green Investing

Global Cannabis Investing - features Investor Ideas Cannabis news

Get News Alerts on Marijuana Stocks

Investorideas.com - Cannabis and Beverages: #CBD Beverages to Become $260 million market by 2022: Sproutly (CSE: $SPR.C) (OTCQB: $SRUTF), Hexo (TSX: $HEXO.TO, OTC: $HYYDF), The Green Organic Dutchman (TSX: $TGOD.TO), (OTC: $TGODF)

Investorideas.com - Cannabis and Beverages: #CBD Beverages to Become $260 million market by 2022: Sproutly (CSE: $SPR.C) (OTCQB: $SRUTF), Hexo (TSX: $HEXO.TO, OTC: $HYYDF), The Green Organic Dutchman (TSX: $TGOD.TO), (OTC: $TGODF)

Cannabis and Beverages: #CBD Beverages to Become $260 million market by 2022: Sproutly (CSE: $SPR.C) (OTCQB: $SRUTF), Hexo (TSX: $HEXO.TO, OTC: $HYYDF), The Green Organic Dutchman (TSX: $TGOD.TO), (OTC: $TGODF)

Point Roberts, WA - November 9, 2018 (Investorideas.com Newswire) Investorideas.com, a global news source covering leading sectors including marijuana and hemp stocks releases a sector snapshot with a focus on the growing interest in cannabis infused beverages and water soluble cannabis solutions.

Cannabis may have been federally legalized for recreational use in Canada this fall but many cannabis companies are looking a year into the future at the next big step in the market; October 17th of 2019 when edibles, oils and infused beverage products can join the Canadian recreational market.

How big is the opportunity? A recent Business Insider news article reported, "The marijuana-infused beverages could become a $600 million market in the US in the next four years. Canaccord estimates CBD beverages will become a $260 million market by 2022, and THC-infused beverages a $340 million market."

Sproutly Canada, Inc. (CSE: SPR), (OTC: SRUTF) is looking to capitalize on this opportunity, announcing today that it has completed the development and formulation of an initial portfolio of functional beverages with its proprietary naturally water soluble cannabinoids ("Infuz2O").

From the news: "The beverages combine recently licensed rights for the proprietary water soluble mineral platform ("MiST Platform") with Infuz20. The initial portfolio consists of three separate cannabis / hemp infused beverages that provide the following functions: a) Focused Energy; b) Stress relief and Relaxation; and, c) Restful sleep support."

"The Company is currently in the midst of medicinal and adult-use brand development, including its functional beverage line. The initial beverages will be ready for consumers if and when Health Canada allows consumer beverage products to be legal for sale."

From the news: "The focus of the Company has been to develop beverages that will distinguish our functional beverages from cannabis/ hemp beverages developed by our competitors. Our competitive advantage is to leverage the suite of proprietary water soluble technologies we have acquired, and create a line of consumer products that taste great and have a functional purpose", said Keith Dolo, Chief Executive Officer. "Our beverages not only cater to the emerging cannabis market but also to the large, functional beverage market that exists today", he added.

Sproutly went on to say, "The functional beverage category is increasingly becoming the popular choice among consumers who are seeking low-calorie, nutrient-dense options as a healthy alternative to traditional beverages. The global functional beverage market is expected to grow at a CAGR of 6.1% to US$93.68 billion by 2019, according to a new study by Grand View Research, Inc. Cannabis in its own right has a long history of being used as a way for users to address wellness and lifestyle needs. Sproutly's functional beverage formulations address major and growing consumer health and wellness needs for the modern lifestyle."

Looking at competitors, big players are following the money in this sector. On October 1st another cannabis beverage announcement came from Molson Coors Canada, the Canadian business unit of Molson Coors Brewing Company, and HEXO Corp. (TSX: HEXO, OTC:HYYDF) regarding the closing of the transaction announced on August 1, 2018, to form a joint venture to pursue opportunities to develop non-alcoholic, cannabis-infused beverages for the Canadian market following legalization. The joint venture, Truss, will be led by former Molson Coors executive, Brett Vye, in the role of Chief Executive Officer.

Vye said, "When consumable cannabis is legalized in Canada, Truss will be ready to make its mark as a responsible leader in providing high-quality beverages for the Canadian consumer."

A Business Insider article last week reported that CEO of Molson Coors, Mark Hunter said "The cannabis market could total $7 billion to $10 billion in Canada alone, of which nonalcoholic cannabis-infused beverages could account for as much as $3 billion, or 30% of the total market."

Sproutly Canada, Inc. has been setting up to enter the beverage space previous to today's news with the company announcing in August that it had completed the acquisition of all of the issued and outstanding shares of Infusion Biosciences Canada Inc. and SSM Partners Inc.

From the news: "We are extremely excited to finalize this Acquisition, enabling Sproutly to commercialize the APP Technology in major regulated markets around the world with innovative cannabis products that target the $50+ billion bottled water and functional beverage market with naturally water soluble molecules from cannabis and hemp", commented Keith Dolo, Chief Executive Officer of Sproutly."

What separates Sproutly and Infusion Biosciences from other cannabis beverage technologies? In a phrase; water oluble, as referenced in today's news by Keith Dolo, CEO.

This may put Sproutly in a league of their own with regards to their technology but other cannabis companies have been eyeing the beverage sector of the market. But as Dole noted, he is confident he can separate his company from the pack.

Not to be left out, The Green Organic Dutchman Holdings Ltd. (TSX: TGOD), (OTC: TGODF) also entered the space announcing, back in June of this year, the launch of a global division focused on the beverage industry.

From the news: "The Green Organic Dutchman Beverage Division will utilize its experience to provide a strategic pathway into the cannabis market for large-scale beverage companies by way of direct investment, joint venture or other suitable opportunities."

Continued: "The focus will be to create industry-leading branded products, and to supply organic base ingredients for use in global beverage brands. Similarities between the cannabis sector, beverage, beverage alcohol and consumer packaged goods industries are apparent. "

As the cannabis market continues its growth curve and legalization allows for more cannabis alternatives, cannabis infused beverages will dramatically change and increase the size of the beverage market of the future.

Technology is key to who gets market share, making it an interesting race for investors to watch.

Investor Ideas stock directory of publicly traded CSE, TSX, TSXV, OTC, NASDAQ, NYSE, ASX Marijuana/Hemp Stocks

About Investorideas.com - News that Inspires Big Investing Ideas

https://www.facebook.com/Investorideaspotcasts/

https://twitter.com/MJInvestorIdeas

https://www.instagram.com/potcasts_investorideas/

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp. Disclosure: this article featuring Sproutly (SPR:CSE / SRUTF:OTCQB) is a paid for article at Investorideas.com - learn more about costs and services https://www.investorideas.com/News-Upload/

Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

Contact Investorideas.com

800-665-0411

Marijuana / Hemp Stocks

Like Marijuana / Hemp Stocks? View our Marijuana / Hemp Stocks Directory

Join our Group on Linkedin - Marijuana / Hemp Stocks - News and Trends in Green Investing

Global Cannabis Investing - features Investor Ideas Cannabis news

Get News Alerts on Marijuana Stocks

Thursday, November 08, 2018

Investorideas.com - Investor Ideas Potcasts #Cannabis News and Stocks on the Move: TSX: $APHA.TO, NYSE: $APHA, CSE: $KBEV.C, TSXV: $KHRN.V

Investor Ideas Potcasts #Cannabis News and Stocks on the Move: TSX: $APHA.TO, NYSE: $APHA, CSE: $KBEV.C, TSXV: $KHRN.V

Delta, Kelowna, BC - November 8, 2018 (Investorideas.com Newswire) www.Investorideas.com, a global news source covering leading sectors including marijuana and hemp stocks and its potcast site, www.potcasts.ca release today's edition of its series, Investorideas.com potcastsCM - cannabis news and stocks to watch plus insight from thought leaders and experts.

Listen to the podcast:

https://www.investorideas.com/Audio/Podcasts/2018/110818-StocksToWatch.mp3

Investor Ideas Potcasts #Cannabis News and Stocks on the Move: TSX: $APHA.TO, NYSE: $APHA, CSE: $KBEV.C, TSXV: $KHRN.V

Hear Investor ideas cannabis potcast on iTunes

Today's podcast overview/transcript:

Good afternoon and welcome to another Investorideas.com Potcast - following Cannabis news, stocks to watch as well as insights from thought leaders and experts.

Today we will be looking at announcements from Aphria Inc. Trading on the TSX and NYSE as APHA, Koios Beverage Corp. trading on the CSE as KBEV and Khiron Life Sciences Corp. trading on the TSX-Venture as KHRN.

But first, according to a new report from New Frontier Data, the authority in data, analytics and business intelligence on the global cannabis industry, the legalization of medical cannabis in Utah and Missouri and legalization of adult-use in Michigan will result in new markets that are projected to account for more than $1.2 billion in additional sales for a combined total of $2.1 billion in total legal sales by 2025. This increase will create more than 30,000 additional cannabis jobs over the same period.

"Cannabis legalization in some form has occurred in nearly 60% of the United States, and based on our research, legal retail sales revenues are currently estimated to be $10.3 billion in 2018; we now project the market to grow to more than $25 billion while supporting more than 642,000 jobs by 2025," said Giadha Aguirre de Carcer, Founder and CEO of New Frontier Data.

The revised projections take into consideration the outcome of four state ballot initiatives:

Michigan passed Proposal 1, legalizing recreational use and making Michigan the fifth largest legal U.S. cannabis market; combined with medical, annual sales are projected to reach $1.9 billion in total legal sales by 2025.

Missouri passed Amendment 2, legalizing state-wide medical cannabis; resulting annual retail sales are projected to reach $111 million by 2025.

Utah voters passed Proposition 2, legalizing medical cannabis; annual retail sales are projected to reach $63 million by 2025.

North Dakota voted down Measure 3, which would have allowed adults to grow, consume and possess as much cannabis as they want, without government oversight and without state taxation; annual recreational sales could have reached $67.5 million by 2025.

Aphria Inc. announced its proposed acquisition of CC Pharma GmbH, a leading distributor of pharmaceutical products to more than 13,000 pharmacies in Germany. The transaction, when closed, will strengthen the Company's end-to-end medical cannabis operations and infrastructure in Germany, a key market in Aphria's international expansion. It is anticipated that the transaction will close in January 2019.

"This acquisition strengthens our foothold in Germany, one of the most highly sought-after medical cannabis markets in the world," said Vic Neufeld, CEO of Aphria. "CC Pharma is cash-flow positive and has significant experience with regulatory requirements and international logistics. It will be a strong addition to Aphria's presence in Germany, providing deeper access to the important pharmacist channel and advancing our ambitious global growth strategy."

Founded in 1999, CC Pharma is a leading importer and distributor of EU-pharmaceuticals for the German market, with over €200 million in annual revenue. Aphria, through its subsidiary Aphria International, previously announced a supply agreement with CC Pharma to export approximately 1,200 kilograms of medical cannabis products from Canada to Germany. With Aphria's experience as a global cannabis leader, the Company will create a new division of CC Pharma dedicated to medical cannabis. CC Pharma operates a production, repackaging and labeling facility at its headquarters in Densborn.

Koios Beverage Corp. announced that the Company will be initiating a clinical study into the impact of CBD on the human brain.

Koios is already conducting a clinical trial on the impact of its nootropic supplements on the human brain, and released preliminary results on Oct. 9, 2018. Koios beverages and supplements contain a proprietary formula of nootropic, brain-enhancing nutrients.

The trial involved mapping the activity of the brain before and after subjects consumed Koios nootropic supplements.

Full clinical brain scans on Koios users show changes in brain activity in three main areas, all of which indicate improved cognitive function.

"The findings, although preliminary, are better than we could have expected," said Chris Miller, CEO of the Company. "Changes in the type of brain activity that we are seeing between the baseline that was mapped at the start of the study, and the effect on participants after several months of consuming our beverages, could have many positive implications."

Vice President of Sales Gina Burrus says the results are helping the Company in the design of future products, and so Koios has decided to launch similar trials of nootropics with CBD.

"It's long been known that CBD can have a dramatic impact on the human brain, all the way from helping people relax to treating people for epilepsy," said Burrus. "However, we don't yet know what impact CBD will have when combined with nootropics, and that's what this study is designed to tell us."

Both studies are being conducted by NeuraPerformance/Neuroptimize Brain Center, the go-to brain lab and physiotherapy clinic for Colorado's elite athletes, including the Denver Broncos football team. The lab's brain-mapping technique involves using sensors to measure the electrical activity within the client's brain.

NeuraPerformance/Neuroptimize is expected to release a full report within the next month, after which it will begin further testing of nootropics and CBDs.

Khiron Life Sciences Corp., an integrated medical cannabis company with its core operations in Colombia, welcomed the initiative presented yesterday by the incoming Government of Mexico through its next secretary of the Interior, Dr. Olga Sánchez Cordero, for the Regulation and Control of Cannabis in Mexico.

The General Law for the Regulation and Control of Cannabis, presented by Dr. Olga Sanchez will establish Mexico among Latin American countries that have legislated the use of cannabis for recreational, medical, scientific, research, industrial and commercial purposes. Mexico has the second largest population in Latin America and 11.7 million potential patients for medical cannabis. (source: IMS Quintiles 2017). The new legislation will develop in more detail the conditions for recreational cannabis use already authorized by judicial decisions, and also define final details for medical use.

Alvaro Torres, Co-founder and CEO for Khiron stated, "Khiron is a leader in the medical cannabis sector in Latin America working with all levels of government, health professionals and patients to establish a safe and regulated cannabis environment. We welcome the presentation made yesterday by the next secretary of Interior, Dr. Olga Sánchez Cordero, and we look forward to the opportunity to work with the administration to develop a strong and successful cannabis industry in Mexico."

Former Mexican President and Khiron board member Mr. Vicente Fox stated, "As a Latin America focused company, Khiron is positioned to maximize the legislation proposed yesterday and to bring the benefits of a legalized cannabis environment to all Mexicans, which has the potential to reduce crime, increase prosperity and improve the health of our citizens."

Investor ideas reminds all listeners to read our disclaimers and disclosures on the Investorideas.com website and this podcast is not an endorsement to buy products or services or securities. Investors are reminded all investment involves risk and possible loss of investment.

Subscribe to the new cannabis podcast series:

https://www.investorideas.com/rss/feeds/Podcasts-Cannabis.xml

Or visit https://www.investorideas.com/Audio/Potcasts.asp

Or www.potcasts.ca

To hear more Investorideas.com podcasts visit: https://www.investorideas.com/Audio/.

Potcasts is now a certified word mark Trademark on the blockchain through Cognate, Inc. CM Certification-Registration Number: 10468217708

Get the cannabis/hemp stock directory as an Investor ideas member, plus get weekly updates with new pot stocks added and get the daily potcast for Investor Ideas #Potcasts #Cannabis News and Stocks on the Move. Learn more https://www.investorideas.com/membership/

About Investorideas.com - News that Inspires Big Investing Ideas

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp. Learn more about Investor ideas podcast and news publication services and costs https://www.investorideas.com/News-Upload/

Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

Investor Ideas does not condone the use of cannabis except where permissible by law. Our site does not possess, distribute, or sell cannabis products.

Learn more about sponsoring this podcast or be a guest and our other branded content opportunities at Investorideas.com